139 related articles for article (PubMed ID: 9546315)
1. Repetitive bone marrow transplantation in nonmyeloablated recipients.
Blomberg M; Rao S; Reilly J; Tiarks C; Peters S; Kittler E; Quesenberry P
Exp Hematol; 1998 Apr; 26(4):320-4. PubMed ID: 9546315
[TBL] [Abstract][Full Text] [Related]
2. Stem cell transplantation in the normal nonmyeloablated host: relationship between cell dose, schedule, and engraftment.
Rao SS; Peters SO; Crittenden RB; Stewart FM; Ramshaw HS; Quesenberry PJ
Exp Hematol; 1997 Feb; 25(2):114-21. PubMed ID: 9015211
[TBL] [Abstract][Full Text] [Related]
3. Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts.
Peters SO; Kittler EL; Ramshaw HS; Quesenberry PJ
Exp Hematol; 1995 May; 23(5):461-9. PubMed ID: 7536685
[TBL] [Abstract][Full Text] [Related]
4. High levels of engraftment with a single infusion of bone marrow cells into normal unprepared mice.
Ramshaw HS; Crittenden RB; Dooner M; Peters SO; Rao SS; Quesenberry PJ
Biol Blood Marrow Transplant; 1995 Dec; 1(2):74-80. PubMed ID: 9118295
[TBL] [Abstract][Full Text] [Related]
5. Engraftment of normal murine marrow into nonmyeloablated host mice.
Quesenberry PJ; Ramshaw H; Crittenden RB; Stewart FM; Rao S; Peters S; Becker P; Lowry P; Blomberg M; Reilly J
Blood Cells; 1994; 20(2-3):348-50. PubMed ID: 7749115
[TBL] [Abstract][Full Text] [Related]
6. Phenotype of the engrafting stem cell in mice.
Quesenberry PJ; Becker P; Stewart FM
Stem Cells; 1998; 16 Suppl 1():33-5. PubMed ID: 11012146
[TBL] [Abstract][Full Text] [Related]
7. Reduction of marrow hematopoietic progenitor and stem cell content is not sufficient for enhanced syngeneic engraftment.
Robinson S; van Os R; Sheridan T; Mauch P
Stem Cells; 2000; 18(2):93-101. PubMed ID: 10742381
[TBL] [Abstract][Full Text] [Related]
8. [Transplantation of mesenchymal derived stem cells followed by G-CSF injection can reconstitute hematopoiesis of lethally irradiated BALB/c mice].
Hu Y; Ma L; Ma GJ; Jiang XY; Zhao CH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb; 24(1):20-4. PubMed ID: 12905834
[TBL] [Abstract][Full Text] [Related]
9. Role of T cells in sex differences in syngeneic bone marrow transfers.
Raveche ES; Santoro T; Brecher G; Tjio JH
Exp Hematol; 1985 Nov; 13(10):975-80. PubMed ID: 3902497
[TBL] [Abstract][Full Text] [Related]
10. Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.
Westerhof GR; Ploemacher RE; Boudewijn A; Blokland I; Dillingh JH; McGown AT; Hadfield JA; Dawson MJ; Down JD
Cancer Res; 2000 Oct; 60(19):5470-8. PubMed ID: 11034090
[TBL] [Abstract][Full Text] [Related]
11. B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation.
Bhattacharyya S; Cowan MJ
Biol Blood Marrow Transplant; 2005 Sep; 11(9):657-71. PubMed ID: 16125636
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic stem cells engraft in untreated transplant recipients.
Wu DD; Keating A
Exp Hematol; 1993 Feb; 21(2):251-6. PubMed ID: 8425562
[TBL] [Abstract][Full Text] [Related]
13. Complete allogeneic hematopoietic chimerism achieved by in utero hematopoietic cell transplantation and cotransplantation of LLME-treated, MHC-sensitized donor lymphocytes.
Hayashi S; Hsieh M; Peranteau WH; Ashizuka S; Flake AW
Exp Hematol; 2004 Mar; 32(3):290-9. PubMed ID: 15003315
[TBL] [Abstract][Full Text] [Related]
14. Engraftment of W/c-kit mutant mice is determined by stem cell competition, not by increased marrow 'space'.
Fleishman RA
Exp Hematol; 1996 Feb; 24(2):209-13. PubMed ID: 8641343
[TBL] [Abstract][Full Text] [Related]
15. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
16. Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice.
Stewart FM; Crittenden RB; Lowry PA; Pearson-White S; Quesenberry PJ
Blood; 1993 May; 81(10):2566-71. PubMed ID: 8098231
[TBL] [Abstract][Full Text] [Related]
17. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
[TBL] [Abstract][Full Text] [Related]
18. [ALA-PDT alleviates graft-versus-host disease in mice following allogenic bone marrow transplantation].
Ran HH; Pan KL; Zhang R; Wang YF
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Oct; 8(5):408-12. PubMed ID: 17052403
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of p-Nitrobenzoic Acid (CAS No. 62-23-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 442():1-306. PubMed ID: 12595921
[TBL] [Abstract][Full Text] [Related]
20. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
